Replies to post #18405 on SiNtx Technologies Inc (SINT)

[XenaLives]

Zimmer Biomet, Smith & Nephew, Medtronic & more: 7 device company notes
Written by Mackenzie Garrity | August 15, 2018 | Print | Email

Here are seven key notes from orthopedic and spine device companies in the past week.

Needham shifted its stock ratings for Medtronic and Zimmer Biomet.

OrthoPediatrics is moving forward with plans to expand its Warsaw, Ind.-based headquarters.

7D Surgical received 510(k) clearance from the FDA for its Cranial Module, a step toward launching the company's Machine-vision Image Guided Surgery system for cranial surgery throughout the U.S.

UBS downgraded Smith & Nephew's stock from "neutral" to "buy" after apprehensions about the company's control over the surgical robots market.

OrthoPediatrics released its 2018 second quarter financial results.

Xtant Medical reported revenues dropped during the second quarter of 2018.

More articles on devices and implants:
Medtronic stock gets upgraded while Zimmer Biomet sees downgrade
OrthoPediatrics plans $1M headquarters expansion: 3 things to know
FDA Approves 7D Surgical's Cranial Surgery

https://www.beckersspine.com/orthopedic-a-spine-device-a-implant-news/item/42209-zimmer-biomet-smith-nephew-medtronic-more-7-device-company-notes.html